WILLIAM HAMILTON: Open Payments
NPI 1447014675 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 47 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $101 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $326 |
| ABBVIE INC. | 20 | $255 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
Products named: VRAYLAR, UZEDY, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
